I don’t have live access to up-to-the-minute news in this moment. Here’s what I found from recent public sources about Medicare Plus, Inc.
- Medicare Plus Inc. in the Philippines has public-facing activity around capital plans and regulatory readiness in 2024–2025, including discussions about increasing capital base to meet regulatory expectations and awaiting SEC approval. This points to ongoing regulatory and financial expansion efforts rather than a single headline event.[2]
- The company has a public newsroom page with announcements and background about partnerships, contracts, and guidance for members, indicating active communications with stakeholders, though specific major news items beyond routine updates aren’t clearly listed in the accessible pages.[5]
- Related coverage in the broader healthcare-insurance domain shows ongoing interest in Medicare-related topics, but that material is more general and not specifically centered on Medicare Plus, Inc. filings or events.[8][9]
If you’d like, I can refine this with targeted searches for:
- Latest company press releases or SEC filings (if applicable) related to Medicare Plus Inc.
- Recent partnerships, capitalization updates, or regulatory approvals in the Philippines
- Any major financial results or leadership announcements
Would you like me to perform a focused search for the latest official statements or regulatory filings from Medicare Plus Inc. in the Philippines? If you have a region or a more precise timeframe in mind, tell me and I’ll tailor the search.
Citations:
- Medicare Plus Inc. capital base efforts and SEC approvals discussions cited from a Philippines-focused report ().
- Public newsroom and article pages showing ongoing announcements and informational content ().
- General medicare-related coverage context (, ).
Sources
Plus Therapeutics Inc: Plus Therapeutics receives Medicare enrollment approval for Cnside diagnostic Plus Therapeutics Inc - Cnside Diagnostics enabled to submit claims for Cnside CSF assay...
www.marketscreener.comCNSide Diagnostics receives Medicare PTAN from CMS, enabling claims for its CSF tumor cell enumeration test. CLFS pricing for CPT 0640U targeted by July 2026.
www.pharmanow.liveHealth maintenance organization provider Medicare Plus Inc. expects to end the year with a P120-million capital base to ensure compliance with the governments order to hike capitalization.
www.philstar.comNews that concerns 65 million Americans: STAT in-depth coverage of Medicare and Medicare Advantage issues, including the expanding role of AI in medicine.
www.statnews.comArticles Seeing Clearly, Living Fully: The Importance of Good Eyesight December 9, 2025 Is Your Matcha Habit Affecting Your Iron Levels? December 1, 2025 When Love Hurts: Signs Your Relationship Is Harming Your Mental Health November 24, 2025 Guide to Packing Emergency Go-Bags in the Philippines November 12, 2025 Flu Season: Staying Healthy in the […]
medicareplusinc.comNewsroom PSMBFI and Medicare Plus Inc. Sign Landmark Agreement to Provide Comprehensive Healthcare Plans for Members of the PNP October 10, 2024 Manila, Philippines – In a significant move to support the health and well-being of the country’s law enforcement officers, the Public Safety Mutual Benefit Fund Inc. (PSMBFI) and Medicare Plus Inc. have signed […]
medicareplusinc.comHOUSTON — HOUSTON — Plus Therapeutics, Inc. on Friday reported a loss of $6.9 million in its first quarter. The Houston-based company said it had a loss of $1.05 per share. The developer of...
www.marketscreener.comCertification critical to broad U.S. market release of the CNSide CSF Assay Platform CNSide now meets key federal and state regulatory requirements,...
www.globenewswire.comHealth Insurance
www.prnewswire.com